Management of ventral hernia defect during enterocutaneous fistula takedown: practice patterns and short-term outcomes from the Abdominal Core Health Quality Collaborative.


Journal

Hernia : the journal of hernias and abdominal wall surgery
ISSN: 1248-9204
Titre abrégé: Hernia
Pays: France
ID NLM: 9715168

Informations de publication

Date de publication:
08 2021
Historique:
received: 05 07 2020
accepted: 16 11 2020
pubmed: 4 1 2021
medline: 3 11 2021
entrez: 3 1 2021
Statut: ppublish

Résumé

An enterocutaneous fistula (ECF) with an associated large hernia defect poses a significant challenge for the reconstructive surgeon. We aim to describe operative details and 30-day outcomes of elective hernia repair with an ECF when performed by surgeons participating in the Abdominal Core Health Quality Collaborative (ACHQC). Patients undergoing concomitant hernia and ECF elective repair were identified within the ACHQC. Outcomes of interest were operative details and 30-day rates of surgical site infections (SSI), surgical site occurrences requiring procedural intervention (SSOPI), medical complications, and mortality. 170 patients were identified (mean age 60 years, 52.4% females, mean BMI 32.3 kg/m Surgeons participating in the ACHQC predominantly resect ECFs and repair the associated hernias with sublay mesh with or without a myofascial release. Morbidity remains high, most closely related to wound complications, as such, concomitant definitive repairs should be entertained with caution.

Sections du résumé

BACKGROUND
An enterocutaneous fistula (ECF) with an associated large hernia defect poses a significant challenge for the reconstructive surgeon. We aim to describe operative details and 30-day outcomes of elective hernia repair with an ECF when performed by surgeons participating in the Abdominal Core Health Quality Collaborative (ACHQC).
STUDY DESIGN
Patients undergoing concomitant hernia and ECF elective repair were identified within the ACHQC. Outcomes of interest were operative details and 30-day rates of surgical site infections (SSI), surgical site occurrences requiring procedural intervention (SSOPI), medical complications, and mortality.
RESULTS
170 patients were identified (mean age 60 years, 52.4% females, mean BMI 32.3 kg/m
CONCLUSIONS
Surgeons participating in the ACHQC predominantly resect ECFs and repair the associated hernias with sublay mesh with or without a myofascial release. Morbidity remains high, most closely related to wound complications, as such, concomitant definitive repairs should be entertained with caution.

Identifiants

pubmed: 33389276
doi: 10.1007/s10029-020-02347-8
pii: 10.1007/s10029-020-02347-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1013-1020

Informations de copyright

© 2021. Springer-Verlag France SAS, part of Springer Nature.

Références

Sarr MG (2016) Abdominal wall surgery in the setting of an enterocutaneous fistula: combined versus staged definitive repair. In: Novitsky YW (ed) BT—hernia surgery: current principle. Springer International Publishing, Cham, pp 379–385
doi: 10.1007/978-3-319-27470-6_36
Dionigi G, Dionigi R, Rovera F et al (2008) Treatment of high output entero-cutaneous fistulae associated with large abdominal wall defects: single center experience. Int J Surg 6:51–56. https://doi.org/10.1016/j.ijsu.2007.07.006
doi: 10.1016/j.ijsu.2007.07.006 pubmed: 17869198 pmcid: 17869198
Slade DAJ, Carlson GL (2013) Takedown of enterocutaneous fistula and complex abdominal wall reconstruction. Surg Clin N Am 93:1163–1183. https://doi.org/10.1016/j.suc.2013.06.006
doi: 10.1016/j.suc.2013.06.006 pubmed: 24035080 pmcid: 24035080
Schecter WP, Hirshberg A, Chang DS et al (2009) Enteric fistulas: principles of management. J Am Coll Surg 209:484–491. https://doi.org/10.1016/j.jamcollsurg.2009.05.025
doi: 10.1016/j.jamcollsurg.2009.05.025 pubmed: 19801322 pmcid: 19801322
Evenson AR, Fischer JE (2006) Current management of enterocutaneous fistula. J Gastrointest Surg 10:455–464. https://doi.org/10.1016/j.gassur.2005.08.001
doi: 10.1016/j.gassur.2005.08.001 pubmed: 16504896 pmcid: 16504896
Visschers RGJ, Damink SWMO, Winkens B et al (2008) Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg 32:445–453. https://doi.org/10.1007/s00268-007-9371-1
doi: 10.1007/s00268-007-9371-1 pubmed: 18175171 pmcid: 18175171
Poulose BK, Roll S, Murphy JW et al (2016) Design and implementation of the Americas Hernia Society Quality Collaborative (AHSQC): improving value in hernia care. Hernia 20:177–189. https://doi.org/10.1007/s10029-016-1477-7
doi: 10.1007/s10029-016-1477-7 pubmed: 26936373 pmcid: 26936373
Haskins IN, Horne CM, Krpata DM et al (2018) A call for standardization of wound events reporting following ventral hernia repair. Hernia 22:729–736. https://doi.org/10.1007/s10029-018-1748-6
doi: 10.1007/s10029-018-1748-6 pubmed: 29429064 pmcid: 29429064
CDC Surgical Site Infection (SSI) Event. https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf . Accessed 14 May 2019
Mayhew D, Mendonca V, Murthy BVS (2019) A review of ASA physical status—historical perspectives and modern developments. Anaesthesia 74:373–379. https://doi.org/10.1111/anae.14569
doi: 10.1111/anae.14569 pubmed: 30648259 pmcid: 30648259
Draus JM, Huss SA, Harty NJ et al (2006) Enterocutaneous fistula: are treatments improving? Surgery 140:570–576. https://doi.org/10.1016/j.surg.2006.07.003 ((discussion 576–8))
doi: 10.1016/j.surg.2006.07.003 pubmed: 17011904 pmcid: 17011904
Carbonell AM, Criss CN, Cobb WS et al (2013) Outcomes of synthetic mesh in contaminated ventral hernia repairs. J Am Coll Surg 217:991–998. https://doi.org/10.1016/j.jamcollsurg.2013.07.382
doi: 10.1016/j.jamcollsurg.2013.07.382 pubmed: 24045140 pmcid: 24045140
Wind J, van Koperen PJ, Slors JFM, Bemelman WA (2009) Single-stage closure of enterocutaneous fistula and stomas in the presence of large abdominal wall defects using the components separation technique. Am J Surg 197:24–29. https://doi.org/10.1016/j.amjsurg.2007.11.026
doi: 10.1016/j.amjsurg.2007.11.026 pubmed: 18639232 pmcid: 18639232
Krpata DM, Stein SL, Eston M et al (2013) Outcomes of simultaneous large complex abdominal wall reconstruction and enterocutaneous fistula takedown. Am J Surg 205:354–359. https://doi.org/10.1016/j.amjsurg.2012.10.013
doi: 10.1016/j.amjsurg.2012.10.013 pubmed: 23375762 pmcid: 23375762
Hodgkinson JD, Maeda Y, Leo CA et al (2017) Complex abdominal wall reconstruction in the setting of active infection and contamination: a systematic review of hernia and fistula recurrence rates. Color Dis 19:319–330. https://doi.org/10.1111/codi.13609
doi: 10.1111/codi.13609
Cheesborough JE, Park E, Souza JM, Dumanian GA (2014) Staged management of the open abdomen and enteroatmospheric fistulae using split-thickness skin grafts. Am J Surg 207:504–511. https://doi.org/10.1016/j.amjsurg.2013.07.040
doi: 10.1016/j.amjsurg.2013.07.040 pubmed: 24315380 pmcid: 24315380
Kugler NW, Bobbs M, Webb T et al (2016) A dual-stage approach to contaminated, high-risk ventral hernia repairs. J Surg Res 204:200–204. https://doi.org/10.1016/j.jss.2016.04.065
doi: 10.1016/j.jss.2016.04.065 pubmed: 27451887 pmcid: 27451887
Petro CC, Rosen MJ (2018) Fight or flight: the role of staged approaches to complex abdominal wall reconstruction. Plast Reconstr Surg 142:38S-44S. https://doi.org/10.1097/PRS.0000000000004847
doi: 10.1097/PRS.0000000000004847 pubmed: 30138264 pmcid: 30138264
Berry SM, Fischer JE (1996) Classification and pathophysiology of enterocutaneous fistulas. Surg Clin N Am 76:1009–1018. https://doi.org/10.1016/s0039-6109(05)70495-3
doi: 10.1016/s0039-6109(05)70495-3 pubmed: 8841361 pmcid: 8841361
Di Saverio S, Tarasconi A, Inaba K et al (2015) Open abdomen with concomitant enteroatmospheric fistula: attempt to rationalize the approach to a surgical nightmare and proposal of a clinical algorithm. J Am Coll Surg 220:e23–e33. https://doi.org/10.1016/j.jamcollsurg.2014.11.020
doi: 10.1016/j.jamcollsurg.2014.11.020 pubmed: 25537306 pmcid: 25537306
Muysoms FE, Miserez M, Berrevoet F et al (2009) Classification of primary and incisional abdominal wall hernias. Hernia 13:407–414. https://doi.org/10.1007/s10029-009-0518-x
doi: 10.1007/s10029-009-0518-x pubmed: 19495920 pmcid: 19495920
Rosen MJ, Krpata DM, Ermlich B, Blatnik JA (2013) A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilizing biologic mesh. Ann Surg 257:991–996. https://doi.org/10.1097/SLA.0b013e3182849871
doi: 10.1097/SLA.0b013e3182849871 pubmed: 23426340 pmcid: 23426340
Itani KMF, Rosen M, Vargo D et al (2012) Prospective study of single-stage repair of contaminated hernias using a biologic porcine tissue matrix: the RICH study. Surgery 152:498–505. https://doi.org/10.1016/j.surg.2012.04.008
doi: 10.1016/j.surg.2012.04.008 pubmed: 22763262 pmcid: 22763262
Blatnik JA, Krpata DM, Jacobs MR et al (2012) In vivo analysis of the morphologic characteristics of synthetic mesh to resist MRSA adherence. J Gastrointest Surg 16:2139–2144. https://doi.org/10.1007/s11605-012-1992-5
doi: 10.1007/s11605-012-1992-5 pubmed: 22907777 pmcid: 22907777
Kelly ME, Behrman SW (2002) The safety and efficacy of prosthetic hernia repair in clean-contaminated and contaminated wounds. Am Surg 68:524–528 ((discussion 528–9))
pubmed: 12079133 pmcid: 12079133
Chamieh J, Tan WH, Ramirez R et al (2017) Synthetic versus biologic mesh in single-stage repair of complex abdominal wall defects in a contaminated field. Surg Infect (Larchmt) 18:112–118. https://doi.org/10.1089/sur.2016.106
doi: 10.1089/sur.2016.106
Warren J, Desai SS, Boswell ND et al (2020) Safety and efficacy of synthetic mesh for ventral hernia repair in a contaminated field. J Am Coll Surg 230:405–413. https://doi.org/10.1016/j.jamcollsurg.2019.12.008
doi: 10.1016/j.jamcollsurg.2019.12.008 pubmed: 31954819 pmcid: 31954819

Auteurs

A Fafaj (A)

Department of General Surgery, Center for Abdominal Core Health, Digestive Disease and Surgery Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A-100, Cleveland, OH, 44195, USA. fafaja@ccf.org.

L Tastaldi (L)

Department of General Surgery, Center for Abdominal Core Health, Digestive Disease and Surgery Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A-100, Cleveland, OH, 44195, USA.
Department of General Surgery, University of Texas Medical Branch, 3100 University Boulevard, Galveston, TX, 77555, USA.

H Alkhatib (H)

Department of General Surgery, Center for Abdominal Core Health, Digestive Disease and Surgery Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A-100, Cleveland, OH, 44195, USA.

S J Zolin (SJ)

Department of General Surgery, Center for Abdominal Core Health, Digestive Disease and Surgery Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A-100, Cleveland, OH, 44195, USA.

S Rosenblatt (S)

Department of General Surgery, Center for Abdominal Core Health, Digestive Disease and Surgery Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A-100, Cleveland, OH, 44195, USA.

L-C Huang (LC)

Department of Biostatistics, Vanderbilt University Medical Center, 1211 Medical Center Dr., Nashville, TN, 37232, USA.

S Phillips (S)

Department of Biostatistics, Vanderbilt University Medical Center, 1211 Medical Center Dr., Nashville, TN, 37232, USA.

D M Krpata (DM)

Department of General Surgery, Center for Abdominal Core Health, Digestive Disease and Surgery Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A-100, Cleveland, OH, 44195, USA.

A S Prabhu (AS)

Department of General Surgery, Center for Abdominal Core Health, Digestive Disease and Surgery Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A-100, Cleveland, OH, 44195, USA.

C C Petro (CC)

Department of General Surgery, Center for Abdominal Core Health, Digestive Disease and Surgery Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A-100, Cleveland, OH, 44195, USA.

M J Rosen (MJ)

Department of General Surgery, Center for Abdominal Core Health, Digestive Disease and Surgery Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A-100, Cleveland, OH, 44195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH